Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Xofluza Shows Favorable Results in Patients at High Risk of Flu Complications in Global PIII: Shionogi
Shionogi said on June 9 that its anti-flu drug Xofluza (baloxavir marboxil) significantly shortened the time to improvement of influenza symptoms compared to placebo in a global PIII study in influenza patients at a high risk of influenza complications. In…
To read the full story
BUSINESS
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026





